An IPRO-led multi-disciplinary panel has reached consensus on essential anticoagulation management elements that need to be communicated to downstream providers upon discharge of at-risk patients from acute care hospitals. The 15 data elements experts agree need to be communicated during transitions from one care setting to another include precise information on recently prescribed and/or discontinued agents; whether patients are new or longstanding users of medications; explicit documentation of when anticoagulation medications should be reduced or discontinued; objective assessments of renal function; and documentation addressing the ability of patients to self-administer and self-monitor medications. The panel’s work is featured in a new article “Defining Minimum Necessary Anticoagulation-Related Communication at Discharge: Consensus of the Care Transitions Task Force of the New York State Anticoagulation Coalition,” by Darren Triller, PharmD, Anne Myrka, BS Pharm, MAT, and colleagues, which appears in the Joint Commission Journal on Quality and Patient Safety (2018; 000:1-11).